Lexington Biosciences, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced net loss was CAD 250,157 compared to CAD 126,858 a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.05 a year ago. For the half year, net loss was CAD 344,591 compared to CAD 330,326 a year ago. Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.09 a year ago.